Explore the Latest Ranibizumab Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Ranibizumab Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Ranibizumab Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Ranibizumab Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Ranibizumab Tenders and beyond.
5281177Belgium Ophthalmologicals Dynamisch aankoopsysteem voor de levering van ranibizumabCountry: BelgiumDeadline10 Jun 20285389599Belgium Ophthalmologicals Dynamisch aankoopsysteem voor de levering van ranibizumabCountry: BelgiumDeadline10 Jun 20287371387Germany Pharmaceutical products Open house Arzneimittelrabattvertrge Ranibizumab in der Darreichungsform Injektionslsung in der Durchstechflasche ATC S01LA04Country: GermanyDeadline05 Mar 20277604637Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Ranibizumab als Durchstechflasche ATC S01LA04Country: GermanyDeadline31 Mar 202710069651Ranibizumab atc code s01la04Country: GermanyDeadline04 Nov 202710115778Germany Pharmaceutical products Abschluss eines nicht exklusiven Rabattvertrages nach 130a Abs 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ranibizumab ATC-Code S01LA04Country: GermanyDeadline27 Oct 202710133187Germany Pharmaceutical products Abschluss nicht exkl Arzneimittel-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum WS Ranibizumab ATC-Code nach WHO S01LACountry: GermanyDeadline31 Dec 202610134030Germany Pharmaceutical products Abschluss nicht exkl Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum WS Ranibizumab ATC-Code nach WHO S01LA04 als InjektCountry: GermanyDeadline31 Dec 202610134287Conclusion not excluding drug discount agreement according to section 130a paragraph 8 sgb v through an open house model for ws ranibizumab atc code according to who s01la04 asCountry: GermanyDeadline01 Jan 202710148516Conclusion not excluding discount agreement according to section 130a paragraph 8 sgb v through an open house model for ws ranibizumab atc code according to who s01la04 as an iCountry: GermanyDeadline01 Jan 202710182477Open house drug discount agreements ranibizumab in the dosage form injection solution in the pre-filled syringe atc s01la04Country: GermanyDeadline03 Nov 202710187608Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Ranibizumab als Fertigspritze ATC S01LA04Country: GermanyDeadline31 Oct 202710191900Germany Pharmaceutical products Open house Arzneimittelrabattvertrge Ranibizumab in der Darreichungsform Injektionslsung in der Fertigspritze ATC S01LA04Country: GermanyDeadline03 Nov 202711785917Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Ranibizumab ATC S01LA04Country: GermanyDeadline29 Feb 202812913809Germany Pharmaceutical products Open House Biologika Rabattvertrge 2026 - 15 RanibizumabCountry: GermanyDeadline30 Jun 202713210398SUMINISTRO DEL MEDICAMENTO RANIBIZUMAB (DOE), DEFERASIROX (DOE) Y OCTREOTIDA (DOE) SUSPENSIÓN PARA TODAS LAS ORGANIZACIONES DE SERVICIOS DE OSAKIDETZACountry: AndorraDeadline04 Sep 202613810621Centralized regional tender for the stipulation of a multi-operator framework agreement for the supply of Aflibercept and Ranibizumab-based medicines and related services to the HeCountry: ItalyDeadline30 Aug 202613875556Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2026 - 31.08.2028Country: GermanyDeadline04 Jul 202813948211Open tender procedure for the supply of drugs under the drug program Aflibercept, Faricymab, Bevacizumab, Ranibizumab and DexamethazoneCountry: PolandDeadline21 Aug 2026
